Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Synthesized molecule holds promise as antitumor agent

07.02.2003


Amphidinolides, a family of natural compounds that have shown promise as powerful antitumor agents, pose problems for cancer researchers because they are found in only minute amounts, and only in microscopic marine flatworms that live off the coasts of Japan and the U.S. Virgin Islands. Nature keeps a tight lock on its supply of amphidinolide.



Work by University of Illinois at Chicago chemistry professor Arun Ghosh may solve this problem. He’s successfully developed a way to synthesize amphidinolides, making potentially abundant quantities available for cancer research. Ghosh and doctoral student Chunfeng Liu reported on their technique in the Feb. 6 online edition of the Journal of the American Chemical Society.

"We wanted to synthesize amphidinolide in the laboratory for subsequent biological studies," said Ghosh. As an antitumor agent, "nobody knows its exact mechanism of action. It could be a microtubule stabilizing agent, like Taxol, or it could cause cellular apopotosis, where cancer cells are killed by chemotherapeutic agents," he said.


Ghosh and Liu began their work in January 2002 and by November, successfully synthesized a highly potent member of this family of compounds, designated amphidinolide T1. They’ve produced about 8 milligrams of the compound in their UIC laboratory and have sent a sample to the National Cancer Institute in Frederick, Md. for testing by Ernest Hamel, a noted expert in cancer research.

While Hamel said he has not yet tested the amphidinolide sample, he added, "its synthesis, of course, is a tour-de-force independent of its biological activity."

Nuclear magnetic resonance spectroscopy and other sophisticated technologies helped establish the chemical structure of many natural amphidinolides. Ghosh used that structural information and applied a technique called retrosynthetic analysis, developed by his post-doctoral mentor, Nobel laureate Elias James Corey, of Harvard University.

"On paper, we break the molecular structure down to its most basic parts, then we design chemical schemes to rebuild it in the laboratory," said Ghosh. "It’s a very complex molecule. Synthesis of a molecule of this nature is an art, and it becomes a challenge of how to put it together in the most elegant way."

Using planned synthetic strategy as a guide, the step-by-step construction of the molecule in the laboratory flask presents enormous challenges. It’s like trying to solve a complex puzzle. "In the end, this synthesis not only gives you a final product," said Ghosh, "it also allows you to discover a lot of important and useful reactions along the way."

An earlier synthetic success of Ghosh’s, the compound laulimalide, is showing promising results in laboratory tests against certain cancers previously treated by the drug Taxol, and has shown the ability to kill cells resistant to Taxol. The UIC chemistry professor hopes amphidinolide will prove to be even more effective as an antitumor agent.

"We hope we can modify the molecule to make it even more potent and more selective," said Ghosh. "Nature has given us only one molecule, but once we’ve synthesized it in the laboratory, we have the potential to make hundreds of thousands of different variations."

"When you look at all the good drugs available, you find about 60 to 70 percent are derived from nature. In the past, molecules like amphidinolides could not be discovered because we didn’t have the technology. Now the power of chemical design and synthesis provides a new tool for drug discovery."

The National Institutes of Health provided funding for Ghosh’s research. He hopes to win additional grants to do in-depth biological studies and begin synthesis of an even more potent member of the amphidinolide family, called amphidinolide N.

"That’s our next target, and we’re up to the challenge," said Ghosh. "The work on amphidinolide T1 was just the beginning. A lot of the story has yet to unfold."

Paul Francuch | EurekAlert!
Further information:
http://www.uic.edu

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Designer cells: artificial enzyme can activate a gene switch

22.05.2018 | Life Sciences

PR of MCC: Carbon removal from atmosphere unavoidable for 1.5 degree target

22.05.2018 | Earth Sciences

Achema 2018: New camera system monitors distillation and helps save energy

22.05.2018 | Trade Fair News

VideoLinks
Science & Research
Overview of more VideoLinks >>>